Works matching IS 00070920 AND DT 2015 AND VI 112 AND IP 6


Results: 23
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer.

    Published in:
    British Journal of Cancer, 2015, v. 112, n. 6, p. 963, doi. 10.1038/bjc.2015.37
    By:
    • Price, T J;
    • Bruhn, M A;
    • Lee, C K;
    • Hardingham, J E;
    • Townsend, A R;
    • Mann, K P;
    • Simes, J;
    • Weickhardt, A;
    • Wrin, J W;
    • Wilson, K;
    • Gebski, V;
    • Van Hazel, G;
    • Robinson, B;
    • Cunningham, D;
    • Tebbutt, N C
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23